Phase III trial of masitinib in paediatric patients with mastocytosis

Trial Profile

Phase III trial of masitinib in paediatric patients with mastocytosis

Planning
Phase of Trial: Phase III

Latest Information Update: 17 Dec 2014

At a glance

  • Drugs Masitinib (Primary)
  • Indications Mastocytosis
  • Focus Registrational; Therapeutic Use
  • Sponsors AB Science
  • Most Recent Events

    • 17 Dec 2014 New trial record
    • 10 Nov 2014 This trial is expected to be initiated in 2015, according to an AB Science media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top